Tenecteplase plus enoxaparin or abciximab was better than tenecteplase plus unfractionated heparin for acute MI
- Defibrillators better than drugs--study. Hensley, Scott // Modern Healthcare;01/10/2000, Vol. 30 Issue 2, p48
Focuses on a study which compared the effectivity of implantable defibrillators and drugs in treating acute heart attacks. Cost of defibrillators; Findings of the study.
- More Statins: Fewer heart attacks. Houlton, Sarah // Pharmaceutical Executive;Sep2002, Vol. 22 Issue 9, p21
Reports that many high-risk patients could benefit from statin therapy, according to a major British study set up by the Medical Research Council and the British Heart Foundation. Safety of long-term statin use; Call for new prescribing guidelines to allow those at risk of cardiovascular events...
- Ensure patients receive the right dose of statins. Korlipara, Krishna // GP: General Practitioner;11/18/2002, p62
Presents advice to general practitioners to ensure patients receive the right dose of statins. Role of statins in reduction of heart attack risk and strokes; Benefits of statins; Reduction in Alzheimer's disease in patients taking statins.
- Clopidogrel beneficial during acute phase of Ml; metoprolol has no overall effect. // Formulary;May2005, Vol. 40 Issue 5, p162
Discusses a study which showed that clopidogrel reduces 28-day mortality in the treatment of patients with acute myocardial infarction (MI) when given on top of standard therapies, but metoprolol has no effect on inhospital mortality when given during the acute phase of MI. Findings of...
- Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care. Vanasse, Alain; Courteau, Josiane; Niyonsenga, Théophile // BMC Cardiovascular Disorders;2006, Vol. 6, p21
Background: Randomized clinical trials showed the benefit of pharmacological and revascularization treatments in secondary prevention of myocardial infarction (MI), in selected population with highly controlled interventions. The objective of this study is to measure these treatments' impact on...
- NEW DRUGS OF THE YEAR: A HOST OF MAJOR BREAKTHROUGHS. Rodman, Morton J. // RN;Apr83, Vol. 46 Issue 4, p63
Part I. Offers information on drugs introduced in 1982. Similarities in calcium channel blockers; Development in the treatment of acute myocardial infarction; Characteristics of cardiovascular drugs.
- Statin use to reduce the incidence of PCI-associated periprocedural MI. Sim, Michael // Cardiology Today;Feb2011, Vol. 14 Issue 2, p15
The article discusses the findings of the ARMYDA and the Novel Approaches for Preventing or Limiting Events II (NAPLES II) trials which both demonstrated the beneficial effects of statins in reducing the incidence of periprocedual myocardial infarction (MI).
- Don't Leave Without This. Harrar, Sari // Prevention;Jun2001, Vol. 53 Issue 6, p177
Discusses evidence which shows that starting statin therapy soon after a heart attack can reduce the risk of a second attack or death, and how heart attack patients should request a statin before being released from the hospital.
- How to beat back a heart attack? With swift and aggressive counterpunching. Comarow, Avery // U.S. News & World Report;01/15/2001, Vol. 130 Issue 2, p51
Reports on treatments for heart attack patients. Use of angioplasty to open clogged arteries; Stents, which are cylinders of metal mesh, which keep arteries open; Statin drugs which lower cholesterol levels and heart attack risks.